Matches in SemOpenAlex for { <https://semopenalex.org/work/W2280492033> ?p ?o ?g. }
- W2280492033 endingPage "84" @default.
- W2280492033 startingPage "74" @default.
- W2280492033 abstract "Parasitic diseases cause ∼500,000 deaths annually and remain a major challenge for therapeutic development. Using a rational design based approach, we developed peptide inhibitors with anti-parasitic activity that were derived from the sequences of parasite scaffold proteins LACK (Leishmania's receptor for activated C-kinase) and TRACK (Trypanosoma receptor for activated C-kinase). We hypothesized that sequences in LACK and TRACK that are conserved in the parasites, but not in the mammalian ortholog, RACK (Receptor for activated C-kinase), may be interaction sites for signaling proteins that are critical for the parasites' viability. One of these peptides exhibited leishmanicidal and trypanocidal activity in culture. Moreover, in infected mice, this peptide was also effective in reducing parasitemia and increasing survival without toxic effects. The identified peptide is a promising new anti-parasitic drug lead, as its unique features may limit toxicity and drug-resistance, thus overcoming central limitations of most anti-parasitic drugs." @default.
- W2280492033 created "2016-06-24" @default.
- W2280492033 creator A5001021574 @default.
- W2280492033 creator A5015344901 @default.
- W2280492033 creator A5016808090 @default.
- W2280492033 creator A5019697239 @default.
- W2280492033 creator A5023672955 @default.
- W2280492033 creator A5030633284 @default.
- W2280492033 creator A5030989702 @default.
- W2280492033 creator A5033369305 @default.
- W2280492033 creator A5038331268 @default.
- W2280492033 creator A5039639608 @default.
- W2280492033 creator A5044906390 @default.
- W2280492033 creator A5046990713 @default.
- W2280492033 creator A5049636970 @default.
- W2280492033 creator A5051342927 @default.
- W2280492033 creator A5051486148 @default.
- W2280492033 creator A5056970213 @default.
- W2280492033 creator A5059455381 @default.
- W2280492033 creator A5076635917 @default.
- W2280492033 creator A5083713888 @default.
- W2280492033 creator A5084536690 @default.
- W2280492033 creator A5084540545 @default.
- W2280492033 creator A5087487089 @default.
- W2280492033 date "2016-04-01" @default.
- W2280492033 modified "2023-10-18" @default.
- W2280492033 title "Scaffold proteins LACK and TRACK as potential drug targets in kinetoplastid parasites: Development of inhibitors" @default.
- W2280492033 cites W1823096434 @default.
- W2280492033 cites W1963542761 @default.
- W2280492033 cites W1964758111 @default.
- W2280492033 cites W1964776972 @default.
- W2280492033 cites W1969785724 @default.
- W2280492033 cites W1979712040 @default.
- W2280492033 cites W1988963904 @default.
- W2280492033 cites W1989266032 @default.
- W2280492033 cites W1990332976 @default.
- W2280492033 cites W1992450378 @default.
- W2280492033 cites W1994406603 @default.
- W2280492033 cites W2003500126 @default.
- W2280492033 cites W2004585452 @default.
- W2280492033 cites W2006404292 @default.
- W2280492033 cites W2010155234 @default.
- W2280492033 cites W2015292449 @default.
- W2280492033 cites W2016184567 @default.
- W2280492033 cites W2021822101 @default.
- W2280492033 cites W2028736889 @default.
- W2280492033 cites W2030190241 @default.
- W2280492033 cites W2033455856 @default.
- W2280492033 cites W2046144222 @default.
- W2280492033 cites W2059737633 @default.
- W2280492033 cites W2063524276 @default.
- W2280492033 cites W2064239254 @default.
- W2280492033 cites W2072914850 @default.
- W2280492033 cites W2080771705 @default.
- W2280492033 cites W2098425296 @default.
- W2280492033 cites W2105105987 @default.
- W2280492033 cites W2106837596 @default.
- W2280492033 cites W2109979991 @default.
- W2280492033 cites W2115903490 @default.
- W2280492033 cites W2117846137 @default.
- W2280492033 cites W2129029860 @default.
- W2280492033 cites W2129612930 @default.
- W2280492033 cites W2130384960 @default.
- W2280492033 cites W2131226058 @default.
- W2280492033 cites W2142853840 @default.
- W2280492033 cites W2145727445 @default.
- W2280492033 cites W2148107316 @default.
- W2280492033 cites W2148446876 @default.
- W2280492033 cites W2150558096 @default.
- W2280492033 cites W2159114486 @default.
- W2280492033 cites W2161303636 @default.
- W2280492033 cites W2163334145 @default.
- W2280492033 cites W2164498868 @default.
- W2280492033 cites W2164581520 @default.
- W2280492033 cites W2167269286 @default.
- W2280492033 cites W2168251353 @default.
- W2280492033 cites W2170643233 @default.
- W2280492033 cites W2172263810 @default.
- W2280492033 cites W2320556745 @default.
- W2280492033 cites W2327883130 @default.
- W2280492033 cites W2416607731 @default.
- W2280492033 doi "https://doi.org/10.1016/j.ijpddr.2016.02.003" @default.
- W2280492033 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4805777" @default.
- W2280492033 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27054066" @default.
- W2280492033 hasPublicationYear "2016" @default.
- W2280492033 type Work @default.
- W2280492033 sameAs 2280492033 @default.
- W2280492033 citedByCount "7" @default.
- W2280492033 countsByYear W22804920332017 @default.
- W2280492033 countsByYear W22804920332018 @default.
- W2280492033 countsByYear W22804920332020 @default.
- W2280492033 countsByYear W22804920332021 @default.
- W2280492033 countsByYear W22804920332022 @default.
- W2280492033 crossrefType "journal-article" @default.
- W2280492033 hasAuthorship W2280492033A5001021574 @default.
- W2280492033 hasAuthorship W2280492033A5015344901 @default.
- W2280492033 hasAuthorship W2280492033A5016808090 @default.
- W2280492033 hasAuthorship W2280492033A5019697239 @default.